EdwardCCooperMD

Associate Professor, Neurology, Baylor College of Medicine

Dr. Cooper is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
6550 Fannin St
Ste 1801
Houston, TX 77030
Phone+1 713-798-8259

Fax+1 713-798-7561

University of California (San Francisco)Residency, Neurology, 1991 - 1994
University of California (San Francisco)Internship, Internal Medicine, 1990 - 1991
Yale School of MedicineClass of 1990

PubMed

Plural molecular and cellular mechanisms of pore domainencephalopathy.
Timothy J Abreo, Emma C Thompson, Anuraag Madabushi, Heun Soh, Nissi Varghese
Biorxiv. 2024-06-26
3 citations
Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment.
Allan Bayat, Stefano Iavarone, Francesco Miceli, Anne V Jakobsen, Katrine M Johannesen
Neurotherapeutics. 2024-01-01
11 citations
KCNA1 gain-of-function epileptic encephalopathy treated with 4-aminopyridine.
Peter Müller, Danielle S Takacs, Ulrike B S Hedrich, Rohini Coorg, Laura Masters
Annals of Clinical and Translational Neurology. 2023-04-01

Von Knopp Biosciences Veröffentlichte Daten Zeigen Wiederherstellung Der Funktion Durch KB-3061 Im Zellmodell Von Genvarianten, Die Eine Epileptische KCNQ2-Enzephalopathie VerursachenSeptember 17th, 2019
Knopp Biosciences Reports Data Demonstrating Restoration of Function by KB-3061 in Cellular Model of Gene Variants Causing KCNQ2 Epileptic EncephalopathySeptember 17th, 2019
Knopp Biosciences Enters Research Collaboration with Baylor College of Medicine to Develop New Treatments for KCNQ2 Neonatal EncephalopathyJanuary 3rd, 2019
Join now to see all